Healthcare - Medical - Devices - NASDAQ - US
$ 2.39
0.42 %
$ 83.2 M
Market Cap
-2.08
P/E
BALANCE SHEET
203 M
ASSETS
37.5 M
LIABILITIES
165 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
908 Devices Inc.
| Current Assets | 174 M |
| Cash & Short-Term Investments | 146 M |
| Receivables | 8.99 M |
| Other Current Assets | 19.1 M |
| Non-Current Assets | 29.2 M |
| Long-Term Investments | 0 |
| PP&E | 9.58 M |
| Other Non-Current Assets | 19.6 M |
| Current Liabilities | 22.5 M |
| Accounts Payable | 1.19 M |
| Short-Term Debt | 4.03 M |
| Other Current Liabilities | 17.3 M |
| Non-Current Liabilities | 14.9 M |
| Long-Term Debt | 7.86 M |
| Other Non-Current Liabilities | 7.08 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Cash & Cash Equivalents | 121.0 | 188.4 | 224.1 | 159.2 | 17.9 | 7.1 |
| Short Term Investments | 24.6 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 9.0 | 10.0 | 16.4 | 6.9 | 5.1 | 6.3 |
| Inventory | 14.9 | 12.5 | 7.9 | 4.6 | 5.2 | 3.5 |
| Other Current Assets | 4.2 | 4.7 | 4.5 | 0.6 | 0.4 | 0.3 |
| Total Current Assets | 173.8 | 215.6 | 252.9 | 171.0 | 28.6 | 17.2 |
| PP&E | 9.6 | 7.0 | 6.8 | 7.1 | 8.6 | 10.0 |
| Intangible Assets | 7.9 | 8.5 | 0 | 0 | 0 | 0 |
| Goodwill | 10.4 | 10.1 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 1.4 | (1.3) | 1.2 | 0.7 | 0.5 | 0.5 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 203.0 | 242.6 | 260.9 | 178.8 | 37.7 | 27.7 |
| LIABILITIES | ||||||
| Accounts Payable | 1.2 | 1.4 | 1.4 | 1.0 | 0.6 | 0.6 |
| Short Term Debt | 4.0 | 2.9 | 2.7 | 2.9 | 1.1 | 0.3 |
| Other Current Liabilities | 6.7 | 7.4 | 5.6 | 3.9 | 2.9 | 2.9 |
| Total Current Liabilities | 22.5 | 19.2 | 14.8 | 10.8 | 6.1 | 4.8 |
| Long Term Debt | 7.9 | 18.0 | 24.0 | 26.0 | 21.7 | 17.6 |
| Deferred Tax Income | 2.4 | 2.7 | 15.0 | 0 | 71.7 | (8.1) |
| Other Liabilities | (7.9) | 0.6 | (4.5) | (5.6) | 72.5 | 55.2 |
| Total Liabilities | 37.5 | 52.0 | 46.3 | 39.8 | 100.8 | 77.9 |
| EQUITY | ||||||
| Common Stock | 33 K | 32 K | 31 K | 27 K | 5 K | 5 K |
| Retained Earnings | (170.6) | (134.2) | (100.6) | (78.5) | (65.6) | (52.3) |
| Other Accumulative Comprehensive Income/Loss | 1.4 | 0.8 | 0 | (178.8) | (65.6) | (2.5) |
| Total Equity | 165.5 | 190.6 | 214.6 | 139.0 | (63.2) | (50.2) |
| Total Liabilities and Equity | 203.0 | 242.6 | 260.9 | 178.8 | 37.7 | 27.7 |
| SHARES OUTSTANDING | ||||||
| Common Shares Outstanding | 32.2 | 31.5 | 28.0 | 27.3 | 26.2 | 19.0 |